Future pandemics and vaccination: Public opinion and attitudes across three European countries.
Identifieur interne : 000077 ( Main/Corpus ); précédent : 000076; suivant : 000078Future pandemics and vaccination: Public opinion and attitudes across three European countries.
Auteurs : Domino Determann ; Esther W. De Bekker-Grob ; Jeff French ; Helene A. Voeten ; Jan Hendrik Richardus ; Enny Das ; Ida J. KorfageSource :
- Vaccine [ 1873-2518 ] ; 2016.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Disease Outbreaks (prevention & control), Female (MeSH), Focus Groups (MeSH), Health Knowledge, Attitudes, Practice (MeSH), Humans (MeSH), Influenza A Virus, H1N1 Subtype (MeSH), Influenza Vaccines (therapeutic use), Influenza, Human (prevention & control), Male (MeSH), Middle Aged (MeSH), National Health Programs (MeSH), Netherlands (MeSH), Patient Acceptance of Health Care (statistics & numerical data), Poland (MeSH), Public Opinion (MeSH), Social Norms (MeSH), Sweden (MeSH), Trust (MeSH), Vaccination (psychology), Young Adult (MeSH).
- MESH :
- chemical , therapeutic use : Influenza Vaccines.
- geographic : Netherlands, Poland, Sweden.
- prevention & control : Disease Outbreaks, Influenza, Human.
- psychology : Vaccination.
- statistics & numerical data : Patient Acceptance of Health Care.
- Adult, Aged, Female, Focus Groups, Health Knowledge, Attitudes, Practice, Humans, Influenza A Virus, H1N1 Subtype, Male, Middle Aged, National Health Programs, Public Opinion, Social Norms, Trust, Young Adult.
Abstract
BACKGROUND
Understanding public opinion and attitudes regarding vaccination is crucial for successful outbreak management and effective communication at the European level.
METHODS
We explored national differences by conducting focus group discussions in The Netherlands, Poland and Sweden. Discussions were structured using concepts from behavioural models.
RESULTS
Thematic analysis revealed that participants would base their vaccination decision on trade-offs between perceived benefits and barriers of the vaccine also taking into account the seriousness of the new outbreak. Except for those having chronic diseases, participants expected a low infection risk, resulting in a low willingness to get vaccinated. Information about the health status of cases was considered important since this might change perceived susceptibility. Participants displayed concerns about vaccine safety due to the limited available time to produce and test vaccines in the acute situation of a new pandemic. Swedish participants mentioned their tendency of doing the right thing and following the rules, as well as to get vaccinated because of solidarity with other citizens and social influences. This appeared much less prominent for the Dutch and Polish participants. However, Swedish participants indicated that their negative experiences during the Influenza A/H1N1 2009 pandemic decreases their acceptance of future vaccinations. Polish participants lacked trust in their national (public) health system and government, and were therefore sceptical about the availability and quality of vaccines in Poland.
CONCLUSIONS
Although participants overall expressed similar considerations, important differences between countries stand out, such as previous vaccination experiences, the degree of adherence to social norms, and the degree of trust in health authorities.
DOI: 10.1016/j.vaccine.2015.12.035
PubMed: 26740251
Links to Exploration step
pubmed:26740251Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Future pandemics and vaccination: Public opinion and attitudes across three European countries.</title><author><name sortKey="Determann, Domino" sort="Determann, Domino" uniqKey="Determann D" first="Domino" last="Determann">Domino Determann</name><affiliation><nlm:affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands; National Institute for Public Health and The Environment, Centre for Nutrition, Prevention and Health Services, PO Box 1 (Internal Postal Code 101), 3720 BA Bilthoven, The Netherlands. Electronic address: d.determann@erasmusmc.nl.</nlm:affiliation></affiliation></author><author><name sortKey="De Bekker Grob, Esther W" sort="De Bekker Grob, Esther W" uniqKey="De Bekker Grob E" first="Esther W" last="De Bekker-Grob">Esther W. De Bekker-Grob</name><affiliation><nlm:affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: e.debekker@erasmusmc.nl.</nlm:affiliation></affiliation></author><author><name sortKey="French, Jeff" sort="French, Jeff" uniqKey="French J" first="Jeff" last="French">Jeff French</name><affiliation><nlm:affiliation>Strategic Social Marketing Ltd, Conford, Liphook GU30 7QW, United Kingdom; Brighton University Business School, Mitras House, Lewes Road, Brighton BN2 4AT, United Kingdom. Electronic address: jeff.french@strategic-social-marketing.org.</nlm:affiliation></affiliation></author><author><name sortKey="Voeten, Helene A" sort="Voeten, Helene A" uniqKey="Voeten H" first="Helene A" last="Voeten">Helene A. Voeten</name><affiliation><nlm:affiliation>Municipal Public Health Service Rotterdam-Rijnmond, PO Box 70032, 3000 LP Rotterdam, The Netherlands. Electronic address: h.voeten@Rotterdam.nl.</nlm:affiliation></affiliation></author><author><name sortKey="Richardus, Jan Hendrik" sort="Richardus, Jan Hendrik" uniqKey="Richardus J" first="Jan Hendrik" last="Richardus">Jan Hendrik Richardus</name><affiliation><nlm:affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands; Municipal Public Health Service Rotterdam-Rijnmond, PO Box 70032, 3000 LP Rotterdam, The Netherlands. Electronic address: j.richardus@erasmusmc.nl.</nlm:affiliation></affiliation></author><author><name sortKey="Das, Enny" sort="Das, Enny" uniqKey="Das E" first="Enny" last="Das">Enny Das</name><affiliation><nlm:affiliation>Centre for Language Studies, Radboud University, PO Box 9103, 6500 HD Nijmegen, The Netherlands. Electronic address: h.das@let.ru.nl.</nlm:affiliation></affiliation></author><author><name sortKey="Korfage, Ida J" sort="Korfage, Ida J" uniqKey="Korfage I" first="Ida J" last="Korfage">Ida J. Korfage</name><affiliation><nlm:affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: i.korfage@erasmusmc.nl.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26740251</idno><idno type="pmid">26740251</idno><idno type="doi">10.1016/j.vaccine.2015.12.035</idno><idno type="wicri:Area/Main/Corpus">000077</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000077</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Future pandemics and vaccination: Public opinion and attitudes across three European countries.</title><author><name sortKey="Determann, Domino" sort="Determann, Domino" uniqKey="Determann D" first="Domino" last="Determann">Domino Determann</name><affiliation><nlm:affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands; National Institute for Public Health and The Environment, Centre for Nutrition, Prevention and Health Services, PO Box 1 (Internal Postal Code 101), 3720 BA Bilthoven, The Netherlands. Electronic address: d.determann@erasmusmc.nl.</nlm:affiliation></affiliation></author><author><name sortKey="De Bekker Grob, Esther W" sort="De Bekker Grob, Esther W" uniqKey="De Bekker Grob E" first="Esther W" last="De Bekker-Grob">Esther W. De Bekker-Grob</name><affiliation><nlm:affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: e.debekker@erasmusmc.nl.</nlm:affiliation></affiliation></author><author><name sortKey="French, Jeff" sort="French, Jeff" uniqKey="French J" first="Jeff" last="French">Jeff French</name><affiliation><nlm:affiliation>Strategic Social Marketing Ltd, Conford, Liphook GU30 7QW, United Kingdom; Brighton University Business School, Mitras House, Lewes Road, Brighton BN2 4AT, United Kingdom. Electronic address: jeff.french@strategic-social-marketing.org.</nlm:affiliation></affiliation></author><author><name sortKey="Voeten, Helene A" sort="Voeten, Helene A" uniqKey="Voeten H" first="Helene A" last="Voeten">Helene A. Voeten</name><affiliation><nlm:affiliation>Municipal Public Health Service Rotterdam-Rijnmond, PO Box 70032, 3000 LP Rotterdam, The Netherlands. Electronic address: h.voeten@Rotterdam.nl.</nlm:affiliation></affiliation></author><author><name sortKey="Richardus, Jan Hendrik" sort="Richardus, Jan Hendrik" uniqKey="Richardus J" first="Jan Hendrik" last="Richardus">Jan Hendrik Richardus</name><affiliation><nlm:affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands; Municipal Public Health Service Rotterdam-Rijnmond, PO Box 70032, 3000 LP Rotterdam, The Netherlands. Electronic address: j.richardus@erasmusmc.nl.</nlm:affiliation></affiliation></author><author><name sortKey="Das, Enny" sort="Das, Enny" uniqKey="Das E" first="Enny" last="Das">Enny Das</name><affiliation><nlm:affiliation>Centre for Language Studies, Radboud University, PO Box 9103, 6500 HD Nijmegen, The Netherlands. Electronic address: h.das@let.ru.nl.</nlm:affiliation></affiliation></author><author><name sortKey="Korfage, Ida J" sort="Korfage, Ida J" uniqKey="Korfage I" first="Ida J" last="Korfage">Ida J. Korfage</name><affiliation><nlm:affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: i.korfage@erasmusmc.nl.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Disease Outbreaks (prevention & control)</term><term>Female (MeSH)</term><term>Focus Groups (MeSH)</term><term>Health Knowledge, Attitudes, Practice (MeSH)</term><term>Humans (MeSH)</term><term>Influenza A Virus, H1N1 Subtype (MeSH)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (prevention & control)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>National Health Programs (MeSH)</term><term>Netherlands (MeSH)</term><term>Patient Acceptance of Health Care (statistics & numerical data)</term><term>Poland (MeSH)</term><term>Public Opinion (MeSH)</term><term>Social Norms (MeSH)</term><term>Sweden (MeSH)</term><term>Trust (MeSH)</term><term>Vaccination (psychology)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Netherlands</term><term>Poland</term><term>Sweden</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Focus Groups</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Influenza A Virus, H1N1 Subtype</term><term>Male</term><term>Middle Aged</term><term>National Health Programs</term><term>Public Opinion</term><term>Social Norms</term><term>Trust</term><term>Young Adult</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Understanding public opinion and attitudes regarding vaccination is crucial for successful outbreak management and effective communication at the European level.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>We explored national differences by conducting focus group discussions in The Netherlands, Poland and Sweden. Discussions were structured using concepts from behavioural models.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Thematic analysis revealed that participants would base their vaccination decision on trade-offs between perceived benefits and barriers of the vaccine also taking into account the seriousness of the new outbreak. Except for those having chronic diseases, participants expected a low infection risk, resulting in a low willingness to get vaccinated. Information about the health status of cases was considered important since this might change perceived susceptibility. Participants displayed concerns about vaccine safety due to the limited available time to produce and test vaccines in the acute situation of a new pandemic. Swedish participants mentioned their tendency of doing the right thing and following the rules, as well as to get vaccinated because of solidarity with other citizens and social influences. This appeared much less prominent for the Dutch and Polish participants. However, Swedish participants indicated that their negative experiences during the Influenza A/H1N1 2009 pandemic decreases their acceptance of future vaccinations. Polish participants lacked trust in their national (public) health system and government, and were therefore sceptical about the availability and quality of vaccines in Poland.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Although participants overall expressed similar considerations, important differences between countries stand out, such as previous vaccination experiences, the degree of adherence to social norms, and the degree of trust in health authorities.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26740251</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2016</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Feb</Month><Day>03</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Future pandemics and vaccination: Public opinion and attitudes across three European countries.</ArticleTitle><Pagination><MedlinePgn>803-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2015.12.035</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(15)01832-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Understanding public opinion and attitudes regarding vaccination is crucial for successful outbreak management and effective communication at the European level.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We explored national differences by conducting focus group discussions in The Netherlands, Poland and Sweden. Discussions were structured using concepts from behavioural models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thematic analysis revealed that participants would base their vaccination decision on trade-offs between perceived benefits and barriers of the vaccine also taking into account the seriousness of the new outbreak. Except for those having chronic diseases, participants expected a low infection risk, resulting in a low willingness to get vaccinated. Information about the health status of cases was considered important since this might change perceived susceptibility. Participants displayed concerns about vaccine safety due to the limited available time to produce and test vaccines in the acute situation of a new pandemic. Swedish participants mentioned their tendency of doing the right thing and following the rules, as well as to get vaccinated because of solidarity with other citizens and social influences. This appeared much less prominent for the Dutch and Polish participants. However, Swedish participants indicated that their negative experiences during the Influenza A/H1N1 2009 pandemic decreases their acceptance of future vaccinations. Polish participants lacked trust in their national (public) health system and government, and were therefore sceptical about the availability and quality of vaccines in Poland.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although participants overall expressed similar considerations, important differences between countries stand out, such as previous vaccination experiences, the degree of adherence to social norms, and the degree of trust in health authorities.</AbstractText><CopyrightInformation>Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Determann</LastName><ForeName>Domino</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands; National Institute for Public Health and The Environment, Centre for Nutrition, Prevention and Health Services, PO Box 1 (Internal Postal Code 101), 3720 BA Bilthoven, The Netherlands. Electronic address: d.determann@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bekker-Grob</LastName><ForeName>Esther W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: e.debekker@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>French</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Strategic Social Marketing Ltd, Conford, Liphook GU30 7QW, United Kingdom; Brighton University Business School, Mitras House, Lewes Road, Brighton BN2 4AT, United Kingdom. Electronic address: jeff.french@strategic-social-marketing.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voeten</LastName><ForeName>Helene A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Municipal Public Health Service Rotterdam-Rijnmond, PO Box 70032, 3000 LP Rotterdam, The Netherlands. Electronic address: h.voeten@Rotterdam.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardus</LastName><ForeName>Jan Hendrik</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands; Municipal Public Health Service Rotterdam-Rijnmond, PO Box 70032, 3000 LP Rotterdam, The Netherlands. Electronic address: j.richardus@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Enny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Language Studies, Radboud University, PO Box 9103, 6500 HD Nijmegen, The Netherlands. Electronic address: h.das@let.ru.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korfage</LastName><ForeName>Ida J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. Electronic address: i.korfage@erasmusmc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017144" MajorTopicYN="N">Focus Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="N">National Health Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011044" MajorTopicYN="N" Type="Geographic">Poland</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011639" MajorTopicYN="Y">Public Opinion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066262" MajorTopicYN="N">Social Norms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035502" MajorTopicYN="N">Trust</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Emerging infectious diseases</Keyword><Keyword MajorTopicYN="N">Europe</Keyword><Keyword MajorTopicYN="N">Focus group discussions</Keyword><Keyword MajorTopicYN="N">Pandemic preparedness</Keyword><Keyword MajorTopicYN="N">Qualitative research</Keyword><Keyword MajorTopicYN="N">Vaccination</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>06</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26740251</ArticleId><ArticleId IdType="pii">S0264-410X(15)01832-0</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2015.12.035</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippePaysBasV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000077 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000077 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippePaysBasV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:26740251
|texte= Future pandemics and vaccination: Public opinion and attitudes across three European countries.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:26740251" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a GrippePaysBasV1
| This area was generated with Dilib version V0.6.35. |  |